Similar articles for PMID: 32194750

Year	Number of Results
2003	1
2004	3
2006	2
2007	2
2008	4
2011	1
2012	2
2013	2
2014	7
2015	11
2016	9
2017	12
2018	17
2019	13
2020	2
2021	1
2022	2
2023	2
2024	0

1

C-X-C motif receptor 3A enhances proliferation and invasiveness of colorectal cancer cells, and is mediated by C-X-C motif ligand 10.

Nozaki E, Kobayashi T, Ohnishi H, Ohtsuka K, Masaki T, Watanabe T, Sugiyama M. Nozaki E, et al. Oncol Lett. 2020 Mar;19(3):2495-2501. doi: 10.3892/ol.2020.11326. Epub 2020 Jan 21. Oncol Lett. 2020. PMID: 32194750 Free PMC article.

2

Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells.

Li H, Rong S, Chen C, Fan Y, Chen T, Wang Y, Chen D, Yang C, Yang J. Li H, et al. Mol Carcinog. 2019 Feb;58(2):171-184. doi: 10.1002/mc.22917. Epub 2018 Oct 9. Mol Carcinog. 2019. PMID: 30302818

3

CXCR3A contributes to the invasion and metastasis of gastric cancer cells.

Yang C, Zheng W, Du W. Yang C, et al. Oncol Rep. 2016 Sep;36(3):1686-92. doi: 10.3892/or.2016.4953. Epub 2016 Jul 19. Oncol Rep. 2016. PMID: 27461521

4

Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?

Urra S, Fischer MC, Martínez JR, Véliz L, Orellana P, Solar A, Bohmwald K, Kalergis A, Riedel C, Corvalán AH, Roa JC, Fuentealba R, Cáceres CJ, López-Lastra M, León A, Droppelmann N, González HE. Urra S, et al. Oncotarget. 2017 Dec 20;9(2):2445-2467. doi: 10.18632/oncotarget.23502. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416784 Free PMC article.

5

Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.

Shen D, Cao X. Shen D, et al. Int J Clin Exp Pathol. 2015 Jul 1;8(7):8091-8. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26339376 Free PMC article.

6

C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.

Smith JS, Alagesan P, Desai NK, Pack TF, Wu JH, Inoue A, Freedman NJ, Rajagopal S. Smith JS, et al. Mol Pharmacol. 2017 Aug;92(2):136-150. doi: 10.1124/mol.117.108522. Epub 2017 May 30. Mol Pharmacol. 2017. PMID: 28559424 Free PMC article.

7

Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.

Wu Q, Dhir R, Wells A. Wu Q, et al. Mol Cancer. 2012 Jan 11;11:3. doi: 10.1186/1476-4598-11-3. Mol Cancer. 2012. PMID: 22236567 Free PMC article.

8

The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells.

Kundu N, Ma X, Brox R, Fan X, Kochel T, Reader J, Tschammer N, Fulton A. Kundu N, et al. Breast Cancer (Auckl). 2019 Oct 3;13:1178223419873628. doi: 10.1177/1178223419873628. eCollection 2019. Breast Cancer (Auckl). 2019. PMID: 31619923 Free PMC article.

9

CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.

Sun WH, Peng TJ, Tang SJ, Lin JY, Wang CY, Fang HJ, Sun KH. Sun WH, et al. J Oral Pathol Med. 2022 Oct;51(9):791-800. doi: 10.1111/jop.13346. Epub 2022 Sep 5. J Oral Pathol Med. 2022. PMID: 35998229

10

Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.

Chakraborty K, Bose A, Pal S, Sarkar K, Goswami S, Ghosh D, Laskar S, Chattopadhyay U, Baral R. Chakraborty K, et al. Int Immunopharmacol. 2008 Feb;8(2):330-40. doi: 10.1016/j.intimp.2007.10.015. Epub 2007 Nov 20. Int Immunopharmacol. 2008. PMID: 18182249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year